Precicely the point of smoking phylomers WW - it gets you thinking about what might really be going on here.
For 5-8 years large pharma companies have underinvested or simply closed their research divisions and bought options on developing science and some are now scrambling to lock down the future pipelines. I'm not sure what impact Trump will have but I suspect US based pharma will be moving more quickly to lock future programs in place before any anti globalisation & TPP rules fall further apart.
It is a great time to be delivering what PYC have and it possibly means we can obtain the big bucks where 2 years ago it would have gone for a few hundred mill easily and investors would never know they were skittle on billion dollar potential. Just the iMYC program alone could be worth that.
I'm not smoking any more - now anything under 5c looks cheap . . .
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)